Boston Scientific · 1 day ago
Marketing Data Analyst II
Boston Scientific is a leader in medical science, committed to solving important health industry challenges. The Marketing Data Analyst II will contribute to data-driven decision-making and provide analytical insights to support the Coronary Therapies Marketing team.
Health CareMedicalMedical Device
Responsibilities
Interpreting data and communicating actionable recommendations to marketing stakeholders
Utilizing analytics and dashboards for data-driven decision-making
Analyzing data to derive insights to inform segmentation strategies
Supporting the pricing analyst on data and preparation for weekly meetings
Collaborating across functions to support building and maintaining data platforms
Developing and maintaining our commercial reporting infrastructure
Assisting with gathering KPIs to measure success against benchmarks
Engaging and developing relationships with marketing partners to foster collaboration
Qualification
Required
Bachelor's degree in Business, Economics, Mathematics or Statistics
Minimum of 3 years' experience in an analytical role in marketing, finance, or similar functional area
Demonstrated strong analytical skills with the ability to communicate findings effectively
Experience in extracting, and synthesizing data into narratives for business partners
Experience querying databases to extract data for analysis
Proven ability to translate large amounts of data into actionable insights
Strong presentation and interpersonal skills
Experience with Salesforce or another CRM platform
Proficiency in Excel, PowerPoint, Tableau, or other data visualization tool
Preferred
Medical Device or Pharmaceutical industry experience
Experience with syndicated datasets from IQVIA, Definitive Healthcare, etc
Company
Boston Scientific
Boston Scientific is a medical technology company that designs and develops medical devices to diagnose and treat a wide range of condition.
Funding
Current Stage
Public CompanyTotal Funding
$10.02B2025-02-21Post Ipo Debt· $1.58B
2024-02-22Post Ipo Debt· $2.17B
2022-03-04Post Ipo Debt· $3.28B
Recent News
BioWorld Financial Watch
2025-12-25
2025-12-12
2025-12-11
Company data provided by crunchbase